GRANT PICKERING - 21 Mar 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
Chief Executive Officer, Director
Signature
/s/ Ron Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
21 Mar 2022
Net transactions value
-$506,763
Form type
4
Filing time
23 Mar 2022, 18:03:36 UTC
Previous filing
04 Mar 2022
Next filing
20 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Options Exercise $25,576 +14,288 +2% $1.79* 718,182 21 Mar 2022 Direct
transaction PCVX Common Stock Sale $347,061 -13,929 -1.9% $24.92 704,253 21 Mar 2022 Direct F1, F2
transaction PCVX Common Stock Sale $9,220 -359 -0.05% $25.68 703,894 21 Mar 2022 Direct F1, F3
transaction PCVX Common Stock Options Exercise $13,804 +7,712 +1.1% $1.79* 711,606 22 Mar 2022 Direct
transaction PCVX Common Stock Sale $189,862 -7,712 -1.1% $24.62 703,894 22 Mar 2022 Direct F1, F4
holding PCVX Common Stock 355,660 21 Mar 2022 By Children's Trusts

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Options Exercise $0 -14,288 -5.1% $0.000000 264,162 21 Mar 2022 Common Stock 14,288 $1.79 Direct F5
transaction PCVX Stock Option (right to buy) Options Exercise $0 -7,712 -2.9% $0.000000 256,450 22 Mar 2022 Common Stock 7,712 $1.79 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported is a weighted-average price. The shares were sold at prices ranging from $24.55 to $25.48. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 The price reported is a weighted-average price. The shares were sold at prices ranging from $25.635 to $25.70. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4 The price reported is a weighted-average price. The shares were sold at prices ranging from $24.20 to $25.02. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F5 The shares subject to the option are fully vested and exercisable.